
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Atherosclerosis target of lipid-lowering therapy: Is Lower LDL cholesterol better?
Author(s)Peter H. Jones, MD
Advertisement
Articles in this issue
over 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentover 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
Inflammatory markers are useful risk assessment toolsover 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
3
5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall
4
Long-term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL
5




























































